Trials / Completed
CompletedNCT03591133
Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)
Phase I Clinical Study of TS-143 in Healthy Adult Male Subjects (Single-Dose Administration)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
To investigate the safety, pharmacokinetics and pharmacodynamics when administering a single dose of TS-143 to Japanese healthy adult males using a placebo-controlled, double-blind, dose-ascending study, in addition to the effects of meals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-143 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-12-24
- Primary completion
- 2016-04-14
- Completion
- 2016-04-14
- First posted
- 2018-07-19
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03591133. Inclusion in this directory is not an endorsement.